September National Five-City Roadshow: Dan Ruo Reproductive Medical Group Expert Meet-and-Greet (Guangzhou / Shanghai / Beijing / Chongqing / Quanzhou) and a Full Analysis of the Global Four-Site Reproductive Medical Network

September National Five-City Roadshow: Dan Ruo Reproductive Medical Group Expert Meet-and-Greet and a Full Analysis of the Global Four-Site Network

Time: 2026/8/21 Author: DanRuo Hospital Views: 199

In September, the official expert team of Dan Ruo Reproductive Medical Group (DanRuo Global) will launch a series of one-to-one consultation meet-and-greets across five Chinese cities (Guangzhou, Shanghai, Beijing, Chongqing and Quanzhou). The events will be attended in person by President Peng Wenlin (chief embryologist), Dr. Huang Lili (senior reproductive clinical specialist) and Dr. Xue Songguo (executive president of Dan Ruo Thailand).

Dan Ruo Reproductive Medical Group has built a global four-site reproductive-medical and assisted-fertility service network covering "Phnom Penh, Cambodia + Bangkok, Thailand + Hong Kong, China + Colombia". Whether you are planning third-generation IVF (PGT/PGS), single or mature-age egg freezing, hereditary-disease blocking, or are a family that has experienced repeated IVF failures, you can bring your previous examination reports and work face-to-face with world-class experts on a full-cycle, personalised plan.

1. Itinerary of the September 2026 Dan Ruo Domestic Meet-and-Greet

The events adopt a one-to-one private consultation format. To ensure the quality of communication and privacy, places at each session are strictly limited and advance booking is required.

Roadshow City

Meet-and-Greet Dates

Suitable For

How to Book

Guangzhou

September 5 – September 6

South-China families planning a pregnancy, repeated transfers without implantation, premature ovarian failure

Follow the official site / official customer service and scan the QR code to book

Shanghai

September 7

East-China advanced-age pregnancy planning, egg/embryo freezing planning, chromosome-abnormality screening

Follow the official site / official customer service and scan the QR code to book

Beijing

September 9

North-China demand for third-generation IVF, complex infertility cases

Follow the official site / official customer service and scan the QR code to book

Chongqing

September 11

South-West-China patients with polycystic ovary syndrome (PCOS) or suboptimal embryo quality

Follow the official site / official customer service and scan the QR code to book

Quanzhou

September 12 – September 13

Southern-Fujian and south-east-coast families needing hereditary-disease blocking or a high blastocyst-formation rate

Follow the official site / official customer service and scan the QR code to book

2. Led by Three Authoritative Experts, Delivering a Full-Cycle Closed-Loop Care Pathway

1. President Peng Wenlin | Chief Embryologist

  • Career background:

    • 2000–2004: technical core member of the reproductive centre of the First Affiliated Hospital of Sun Yat-sen University (the birthplace of mainland China's first third-generation IVF baby).

    • 2004–2006: laboratory head of the reproductive centre of Hong Kong Sanatorium & Hospital, where he completed Hong Kong's first assisted conception using in-vitro maturation of immature eggs; the Hong Kong "Headline Daily" reported that "Hong Kong's artificial-conception success rate rivals that of foreign countries".

    • 2006–2014: laboratory head of New Hope Fertility Center in the United States.

    • 2014–2017: founder and laboratory head of Macau Ivy Medical Centre.

    • 2018 to present: director of Dan Ruo Reproductive Medical Group; president and head of laboratory of the DanRuo Hospital in Cambodia.

  • Specialties: One of the first cohort of embryologists in China to perform third-generation IVF, with nearly 20 years of deep work in the field. He is proficient in embryo biopsy and PGS/PGD technology, developed and improved a new generation of egg-freezing solution, and created a unique, fine-culture system for repeated IVF failures and poor embryo quality, significantly improving blastocyst-formation and healthy live-birth rates.

2. Dr. Huang Lili | Senior Reproductive Clinical Specialist

  • Career background:

    • Has focused on reproductive medicine since 2005.

    • PhD in obstetrics, gynaecology and reproductive endocrinology from Sun Yat-sen University; formerly of the reproductive centre of the Second Affiliated Hospital of Sun Yat-sen University (Sun Yat-sen Memorial Hospital).

    • Funded by the Ministry of Education's "Overseas Training Programme for Young Backbone Teachers" to visit Massachusetts General Hospital (MGH), Harvard University, USA.

    • Founder and clinical lead of Macau Ivy Medical Centre.

    • Senior reproductive clinical specialist at DanRuo Hospital.

  • Specialties: Skilled at designing individualised ovulation-induction protocols and proficient in the prevention and management of abnormal stimulation responses and complications; deep expertise in fertility-health management for polycystic ovary syndrome (PCOS), endometriosis and diminished ovarian reserve (DOR), with a strong understanding of the coordination between the clinic and the embryo laboratory.

3. Dr. Xue Songguo | Associate Researcher / Executive President, Dan Ruo Thailand

  • Academic and translational achievements:

    • Led 4 projects including National Natural Science Foundation of China and Shanghai Natural Science Foundation grants.

    • Published more than 20 academic papers as first or corresponding author in international journals.

    • Held more than 20 invention patents granted in China, the United States, Australia and other jurisdictions.

    • Led the translation of 4 core reproductive-medicine patent products:

      1. Vitrification freezing / thawing solution system (greatly improving egg and embryo freeze-thaw survival rates).

      2. Single-sperm freezing carrier Cryopiece 2.0 (a breakthrough for extreme severe oligo-astheno-teratozoospermia).

      3. Laser-free biopsy needle Flickamate / BXguard (minimising mechanical damage to the embryo during biopsy).

      4. Closed vitrification freezing system iClean (providing clean, safe ultra-low-temperature storage in liquid nitrogen).

3. Dan Ruo Reproductive Medical Group: A Global "Four-Site" Service Network

To meet the diverse, lawful, compliant and high-quality assisted-fertility needs of different families, Dan Ruo Reproductive Medical Group has built a four-site coordinated service system spanning Asia and the Americas:

  1. DanRuo Hospital, Phnom Penh, Cambodia: has a complete reproductive-medicine management system and a high-specification, constant-temperature-and-humidity clean laboratory, providing compliant, cost-effective and high-success-rate overseas third-generation IVF (PGT) and fertility-preservation services — a highly regarded directly operated flagship hospital in Asia.

  2. Dan Ruo DRC, Bangkok, Thailand: leveraging Bangkok's position as an international medical-tourism hub, it is equipped with top-tier international medical facilities and a comfortable care environment, offering convenient frontier reproductive-medicine consultation, stimulation conditioning and full-process overseas treatment support.

  3. Dan Ruo, Hong Kong, China: relying on Hong Kong's leading international medical resources and convenient transport hub, it provides efficient pre-treatment assessment, pregnancy-preparation planning and international reproductive-medical liaison for clients in the Greater Bay Area and mainland China.

  4. Dan Ruo Reproductive Centre, Americas · Colombia: establishing a compliant assisted-reproduction channel in the Americas with a sound and inclusive legal-support framework, offering lawful, safe and high-quality, locally delivered full-cycle reproductive solutions for diverse families and clients with specific reproductive needs worldwide.

4. Frequently Asked Questions

Q1: What materials should I prepare to attend this Dan Ruo domestic roadshow meet-and-greet?

A: It is recommended to bring the couple's complete examination reports from within the last six months:

  • Female partner: AMH, six sex-hormone tests, basal antral-follicle ultrasound (AFC), fallopian-tube tests, hysteroscopy report, etc.

  • Male partner: routine semen analysis and sperm DNA fragmentation index (DFI) report.

  • Prior IVF history: ovulation-induction medication records from earlier cycles, fertilisation rates, embryo-development/blastocyst-culture records, and PGS/PGD chromosome-screening reports.

Q2: How should I choose among the four sites (Phnom Penh, Bangkok, Hong Kong, Colombia)?

A: The expert team will assess your physical indicators, fertility goals, budget and ease of cross-border travel during the meet-and-greet, and recommend the most suitable site and a customised plan.

Q3: How do I book a September one-to-one private consultation with an expert across the five cities?

A: Visit the official website https://incitaivf.com/ and submit your details; after review, a dedicated consultation slot will be scheduled for you.

This article is general information published by DanRuo Hospital. It does not constitute medical advice, diagnosis or a guarantee of any outcome. Individual results vary.

400-618-5161
LINE QR code
WhatsApp QR code
WeChat QR code
Telegram QR code